Navigation Links
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Date:2/6/2012

SAN DIEGO, Feb. 6, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter and year ended December 31, 2011.

  • Total revenue for the quarter ended December 31, 2011 was $164.9 million, which included net product sales of $160.9 million.
  • Non-GAAP operating income for the quarter ended December 31, 2011 was $17.6 million, compared to a non-GAAP operating income of $22.9 million for the same period in 2010.
  • Full year non-GAAP operating income was $25.7 million, compared to a non-GAAP operating loss of $4.4 million in 2010.
  • Cash, cash equivalents, short-term investments and restricted cash totaled $214.6 million at the end of the quarter.

  • "Our strong execution in 2011 has positioned us to enter 2012 with an extraordinary opportunity to maximize shareholder value. We generated positive operating cash flow, reacquired the full rights to the exenatide franchise, expanded the approved uses for BYETTA, and, most importantly, positioned ourselves well to successfully launch BYDUREON in the U.S. following its recent approval," said Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals. "We will also work to secure a new partner for exenatide outside the U.S. to advance our commitment to diabetes patients around the world, and continue to invest strategically in value-driving opportunities while continuing our focus on financial discipline."

    Highlights of Amylin's Fourth Quarter and Recent Activities

  • Received U.S. Food and Drug Administration (FDA) approval for BYDUREON™ (exenatide extended-release for injectable suspension) – the first and only once-weekly medication approved in the U.S. and the European Union for the treatment of type 2 diabetes. BYDUREON will be available in pharmacies throughout the U.S. later this month.

  • '/>"/>
    SOURCE Amylin Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
    2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
    3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
    4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
    5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
    6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
    7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
    8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
    9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
    10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
    11. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/16/2014)... , Sept. 16, 2014   Vestagen Technical ... the patient experience at hospitals. The myComfort™ line of ... active barrier fabric that is fluid repellant, breathable and ... inhibit the growth of bacteria on the fabric i ... clothing plays in the chain of transmission. We want ...
    (Date:9/16/2014)... , Sept. 16, 2014 Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... product to receive formal designation as a "Promising Innovative ... Scheme" (EAMS) launched in the UK in April 2014. ... process for early access approval under the EAMS.  ...
    (Date:9/16/2014)... 2014 CorMedix Inc. ("CorMedix") (NYSE MKT: ... commercializing therapeutic products for the prevention and treatment ... amendment and restatement of its outstanding Series C-2, ... warrants, as well as the warrants issued in ... to remove anti-dilution, price reset and certain change ...
    Breaking Medicine Technology:New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3
    ... 2011 Cellular Dynamics International (CDI) today announced the ... Blood demonstrating for the first time a methodology ... of banked blood samples through the creation of induced ... "Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent ...
    ... Advanced Sterilization Products (ASP) announced today the ... GLOSAIR™ Healthcare Environmental Decontamination – that provides effective, ... operating suites to reduce the risk of patient ... scientific consensus that the patient environment is a ...
    Cached Medicine Technology:Cellular Dynamics International Unlocks the Potential of Banked Blood Samples 2ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 2ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 3ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 4ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 5
    (Date:9/17/2014)... In honor of National Health IT Week Sept. ... professionals for gaining a competitive edge in the healthcare ... demand for qualified health IT professionals are at an ... differentiating factor when filling a position. The skill most ... clinical workflow and terminology experience. American Sentinel offers ...
    (Date:9/17/2014)... (PRWEB) September 17, 2014 On October ... wellness to the lineup at Techmanity, a celebration of ... next generation of tech events,” Techmanity will host the ... excited to join the ranks of Cisco, PayPal, Samsung, ... ever Silicon Valley Technology Conference. , Voom was created ...
    (Date:9/17/2014)... Presence Technology, a multinational provider of ... 10.0, which incorporates significant enhancements to meet the ... The Contact Center Agents and Supervisors will have ... a better feel for the performance of their ... who requires additional coaching or mentoring to raise ...
    (Date:9/16/2014)... (PRWEB) September 17, 2014 Top10BestSEOHosting.com ... announced the most recommended companies for the webmasters ... at affordable rates. , The senior spokesman ... http://www.arvixe.com/6883.html ), Bluehost and HostMonster are the excellent ... managed to provide a wide range of advanced ...
    (Date:9/16/2014)... report a poorer experience of care during pregnancy and ... care, suggests a new study published today (17 September) ... Gynaecology ( BJOG ). , Differences in health ... many areas and have provided the focus for national ... , The Oxford University study, funded by the National ...
    Breaking Medicine News(10 mins):Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2Health News:Top10BestSEOHosting.com: Arvixe Is One Of The Best SEO Hosting Suppliers 2Health News:A greater focus on socially disadvantaged women is needed to improve maternity care in England 2
    ... the most common form of brain cancer might fare better ... alone . ,Based on findings of the study it ... known as glioblastoma receive surgery to remove as much of ... The current study compared 573 patients with glioblastomas who were ...
    ... to a study in Journal of Dental Research, caries in ... ,A primary tooth can have caries for a wide ... socio-economic status, years of exposure to water fluoridation, disturbance to ... all these differences, can caries in primary teeth have long-term ...
    ... variant that may increase the risk of late-onset Alzheimer’s ... understanding of the disease and new prevention and treatment ... specific changes in the gene in a protein called ... ,In previous studies, researchers studied Alzheimer’s patients and ...
    ... recent issue of Journal of American Medical Association, researchers have ... in delaying the vaccination schedules of the children resulting in ... ,According to the latest study, most of the ... years of age in children often gets delayed due to ...
    ... people it was found that men who drank six cups ... 12 to 18 years, while women who drank that amount ... their study revealed an unequivocal evidence for an inverse and ... other risk factors. However researchers say the reasons for ...
    ... paper presented at American College of Cardiology, laughter can ... presenter of the paper Michael Miller, MD, director of ... medicine at the University of Maryland in Baltimore, had ... healthy and 150 people suffering cardiac problems. ,The ...
    Cached Medicine News:
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: